7Lubien E,Demaria A,Krishnaswanay P,et al.Utility of B-natriuretic peptide levels in detecting diastolic dysfunction[J].Circulation.2002,105(50):595-600.
8Tang WHW,Cirod JP,Lee MJ,et al.Plasma B-type peptide levels in ambulatory patients with established chronic symptomatic systolic heart failure[J].Circulation.2003,108(5):2964-2966.
9Berger R,Huelsman M,Steekerk,et al.B-type natriuretic peptide predicts Sudden death in patients with chronic heartfailure[J].Circulation.2002,105:2391-2396.
10Maisel as,Krishnaswamy P,Nowak RM,et al.Rapid meraurement of B-type natriuretic in the emergency diagnosis of heart failure[J].N Eng J Med.2002,34(7):161-167.
2Knaus WA, Draper EA,Wagner DP , etal. APACHE II: a severity of disease classification system[J]. Crit Care Med, 1985, 13 (10):818-824.
3Theroux P, Armstrong PW, Mahaffey KW, et al. Prognostic significance of blood markers of inflammation in patients with ST-segment elevation myocardial infarction undergoing primary angioptasty and effects of pexelizumab, a C5 inhibitor: a substudy of the COMMA trial[J]. Eur Heart J, 2005, 26(19): 1964-1970.
4Zhang C, Xu X, Potter BJ, et al. TNF-alpha contributes to endothelial dysfunction in ischemia/reperfusion injury [J]. Arterioseler Thromb Vasc Biol, 2006, 26(3) : 475-480.
5Bouman CS, Oudernans-Van Straaten HM, et al. Effects of early high-volume continuous veno-venous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: a prospective randomized trial[J]. Crit Care Med, 2002, 30 (10) : 2205-2211.
6Ronco C, BoneUo M, Bordoni V, et al. Extracorporeal therapies in non-renal disease: treatment of sepsis and the peak concentration hypothesis[J].Bood Purif, 2004, 22(1): 164-174.
7王吉耀.内科学[M].北京:人民卫生出版社,2003.884.
8Hartner A, Cordasic N, Klan/e B, et a|. Renal protection by low dose irbesartan in diabetic nephropathy is paralleled by a reduction of inflarnrnatlon,not of endoplasrnic reticulurn stress[J]. Biochirni- ca et Biophysica Acta (BBA) - Molecular Basis of Disease,2014,1842(4) :558 -565.
